Related by context. All words. (Click for frequent words.) 70 Bazedoxifene 70 RhuDex ® 69 antibody MAb 69 UPLYSO 69 thalidomide Thalomid 69 volociximab 69 Nexavar sorafenib 69 LymphoStat B belimumab 69 Yondelis ® 69 Immunotherapeutic 68 Kosan dependence 68 Temsirolimus 68 LymphoStat B TM 68 Cimzia TM 68 YONDELIS R 68 UVIDEM 68 PDE# inhibitors 68 Fludara ® 68 Velcade bortezomib 68 methylnaltrexone bromide 68 Peginterferon alfa 2b 68 refractory chronic lymphocytic 68 R sorafenib tablets 68 MAGE A3 ASCI 68 Junovan 67 G#DT 67 Allovectin 7 67 HuLuc# 67 Evoltra ® 67 IMA# 67 Aviptadil 67 Tykerb lapatinib 67 Soliris eculizumab 67 IL# PE#QQR 67 Xcytrin R 67 Ocrelizumab 67 tramiprosate Alzhemed TM 67 PDE4 inhibitor 67 Icatibant 67 Tibotec BVBA 67 YONDELIS 67 radiation sensitizer 67 Personalized Immunotherapy 67 oral prodrug 66 investigational humanized monoclonal antibody 66 HuMax TAC 66 XL# XL# 66 PNP inhibitor 66 acyclovir Lauriad R 66 SPRYCEL ® 66 Kuvan R 66 Proxinium TM 66 Initiates Phase III 66 Stimuvax R 66 Vernakalant 66 Archexin 66 Insegia 66 oxaliplatin Eloxatin 66 CDP# 66 Annamycin 66 IMC #B 66 CYT# potent vascular disrupting 66 Aflibercept 66 JAK2 inhibitor 66 PGL# 66 oncolytic virus therapies 66 Romiplostim 66 HQK 66 evaluating tivozanib 66 Somatuline Depot 66 Wellstat 66 Bendamustine 66 Mepact 66 RhuDex TM 66 Files Investigational 66 thetreatment 66 Civacir 66 Hedgehog Pathway Inhibitor 66 Tyzeka Sebivo 66 phase IIb trial 66 Panzem R 66 immunotherapeutic vaccine 66 MKC# MT 66 RhuDex R 66 OvaRex ® MAb 66 GW# [003] 66 Campath ® 66 PHX# 66 pafuramidine maleate 66 CONBRIZA 66 AEG# 66 proteasome inhibitor 66 Gleevec imatinib mesylate 66 SinuNase ™ 66 Triapine R 66 Potelligent Technology 65 Pegloticase 65 Marqibo TM 65 Neulasta R 65 mifamurtide 65 non nucleoside inhibitor 65 TLR9 agonist 65 Zalypsis 65 Genentech Rituxan 65 rasagiline tablets 65 Completes Patient Enrollment 65 Recombinant Human 65 glucokinase activator 65 relapsed leukemia 65 Epratuzumab 65 Trobalt 65 histamine dihydrochloride 65 Cloretazine 65 IgG1 monoclonal antibody 65 Squalamine 65 Evoltra 65 Somatuline R Depot 65 Initiates Phase II 65 Oglemilast 65 Phase IIb clinical trials 65 KRYSTEXXA TM pegloticase 65 Dyloject TM 65 PI3K/Akt pathway inhibitor 65 TheraCIM 65 Modrenal R 65 pediatric acute lymphoblastic 65 ATL/TV# 65 kidney urologic 65 Soliris TM eculizumab 65 FOLOTYN ® 65 Cx# [002] 65 Revlimid lenalidomide 65 MEDAREX 65 Vicriviroc 65 BENLYSTA ® 65 Hepatitis C HCV 65 Prestara TM 65 SinuNase TM 65 Granted Orphan Drug 65 Cetrorelix 65 Ceflatonin R 65 Panzem R NCD 65 Albugon 65 generation purine nucleoside 65 Loramyc 65 Initiates Enrollment 65 trastuzumab DM1 T DM1 65 XL# anticancer compounds 65 Onconase 65 NPC 1C 65 GVAX ® 65 PrevOnco 65 Initiates Clinical 65 Pafuramidine 65 Orphan Status 65 CIMZIA r 65 LEVADEX ™ 65 Zenvia ™ 65 antisense inhibitors 65 IV Busulfex 65 BioNumerik 65 Receives Orphan Drug Designation 65 Safinamide 65 Tezampanel 65 acetonide FA 65 Alvesco R 65 Maribavir 65 vosaroxin 65 Daclizumab 65 Selective Electrochemical Tumor Ablation 65 Valortim TM 65 Phase #b/#a clinical 65 diarrhea predominant irritable 65 Hsp# Inhibitor 65 Meets Primary Endpoint 65 Onrigin 65 Orencia abatacept 65 Proquin XR 65 Virulizin ® 65 PF # [002] 65 orally administered inhibitor 65 Files IND 65 Aplidin 65 Nexavar ® 65 Vitrasert R 65 ACOMPLIA R 64 midstage clinical 64 Ixempra 64 Initiate Clinical Trial 64 SNT MC# 64 NEUPREX R 64 Fx #A 64 WILEX 64 Fresenius Biotech 64 Vectibix panitumumab 64 BEMA TM Fentanyl 64 dextromethorphan quinidine 64 GRN# 64 Gleevec Glivec 64 Leukine ® 64 Saforis 64 chimeric monoclonal antibody 64 TELINTRA 64 cathepsin K inhibitor 64 HepeX B 64 REBETOL combination therapy 64 Begins Dosing 64 Solazed TM 64 Lenalidomide 64 Friedreich Ataxia FRDA 64 R lenalidomide 64 EndoTAG TM -1 64 OncoVex 64 TBC# 64 cinacalcet HCl 64 IMiDs ® compound 64 Canvaxin 64 Aplidin R 64 SILENOR 64 Ridaforolimus 64 etanercept Enbrel 64 Factor VIIa 64 Taiho Pharmaceutical 64 StaphVAX R 64 apricitabine ATC 64 Phase lll 64 IMiDs R 64 ARIKACE ™ 64 Alvesco ® 64 hoFH 64 Panitumumab 64 AstraZeneca Iressa 64 inhaled AAT 64 Arcalyst 64 PKC# 64 Thiovir 64 Prosaptide 64 Nycomed GmbH 64 Eraxis 64 FDA APPROVES 64 vidofludimus 64 LEVADEX TM 64 Ceflatonin 64 Cimzia certolizumab pegol 64 Deforolimus 64 ATL# [001] 64 Troxatyl 64 phase III isavuconazole 64 MGd 64 Glufosfamide 64 EGRIFTA TM 64 pan HDAC inhibitor 64 OvaRex 64 Junovan TM 64 tramiprosate ALZHEMED TM 64 paclitaxel Taxol ® 64 HuMax CD4 64 ONCASPAR 64 Patients Treated With 64 candidate deforolimus 64 Cloretazine ® 64 Xanafide 64 BLA filing 64 therapeutic monoclonal antibody 64 alvespimycin 64 Aloxi ® 64 Glybera R 64 Dalbavancin 64 ANTEGREN 64 initiated Phase Ib 64 mertansine 64 ORENCIA R 64 Combination REOLYSIN R 64 BioSante Pharmaceuticals Announces 64 Initiates Clinical Trial 64 zanolimumab 64 Collategene 64 novel VDA molecule 64 Evoltra R 64 RECOTHROM R 64 MyVax R 64 Xeloda ® 64 Novolimus 64 cetuximab Erbitux ® 64 benign prostatic hypertrophy BPH 64 rilonacept 64 Factor Xa inhibitor 64 Phase Ib II 64 recombinant biopharmaceutical 64 Zavesca r 64 Zorbtive TM 64 vapreotide acetate 64 P#X# antagonist 64 R Saizen R 64 Anidulafungin 64 IMiDs ® 64 beta 1a 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 HuMax 64 Romidepsin 64 Xyrem ® 64 SUTENT ® 64 Pimavanserin 64 Rituxan rituximab 64 evaluating satraplatin 64 RhuDex 64 dacetuzumab 64 IV acetaminophen 64 mitogen activated ERK kinase 64 SYN# 64 pemetrexed Alimta 64 candidate epratuzumab 64 TRACON Pharmaceuticals 64 Prestara 64 PrevOnco ™ 64 Specifid 64 VivaGel ™ 64 Voreloxin 64 MOVIPREP R 63 TYZEKA 63 apoptosis inducer 63 histone deacetylase inhibitor 63 metastatic malignant 63 Corlux 63 VitiGam 63 IV APAP 63 Prodarsan R 63 Initiates Clinical Trials 63 ospemifene 63 Spiegelmer ® 63 Increlex TM 63 AVASTIN 63 ARRY # 63 rhMBL 63 Xenazine ® 63 Severe Sepsis 63 Unit Dose Budesonide 63 novel therapeutic antibodies 63 RECOTHROM ® 63 mTOR mammalian target 63 JOULFERON 63 Vion Pharmaceuticals 63 virus HCV protease inhibitor 63 OHR/AVR# 63 STEDESA 63 LUCASSIN 63 bortezomib Velcade 63 deforolimus 63 RELISTOR ® 63 Certolizumab pegol 63 Angiox ® 63 DPX Survivac 63 treat chronic sinusitis 63 Tasimelteon 63 Urocortin 2 63 Noscira 63 nephropathic cystinosis 63 alemtuzumab Campath 63 Xelox 63 Muraglitazar 63 ixabepilone 63 Zemiva TM 63 SYCREST 63 OMNARIS HFA 63 Tracleer r 63 DEB# 63 Gamunex C 63 lymphoid malignancies 63 personalized immunotherapy 63 BRILINTA 63 Submits Biologics License Application 63 hormone LHRH antagonist 63 Myocet 63 cMET 63 Fc fusion protein 63 Manja Bouman CEO 63 Omacetaxine 63 oropharyngeal candidiasis 63 TELINTRA R 63 BCR ABL inhibitor 63 Fodosine 63 Initiates Phase 2b 63 NV1FGF 63 PEGylated anti 63 ONCONASE R 63 demethylating agent 63 Crofelemer budesonide foam 63 Eribulin 63 Silodosin 63 efalizumab 63 Marketing Authorisation Application 63 OMAPRO ™ 63 Lovaza TM 63 hypereosinophilic syndrome 63 Omigard TM 63 ADP receptor antagonist 63 lumiliximab 63 Serdolect ® 63 Ambrisentan 63 Sycrest 63 Granulocyte Colony Stimulating Factor 63 Vimpat ® lacosamide 63 Cancidas 63 intravenous AAT 63 Herceptin trastuzumab 63 markets HP Acthar 63 human C1 inhibitor 63 investigational immunotherapy 63 Retacrit 63 Lodotra 63 Fast Track Status 63 vinorelbine tartrate 63 antiplatelet agent 63 Trovax 63 BXT # 63 BCR ABL inhibitors 63 WILEX AG 63 Aryplase 63 INTEGRILIN R eptifibatide Injection 63 targeted radiotherapeutic 63 sorafenib tablets 63 TRX1 63 SUPPRELIN R LA 63 Sanvar 63 motexafin gadolinium Injection 63 MAb therapy 63 selective S#P# receptor agonist 63 ATG Fresenius S 63 Desvenlafaxine 63 Clevudine 63 essential thrombocythemia ET 63 docetaxel Taxotere ® 63 vinca alkaloid 63 OvaRex R 63 Hodgkin lymphoma HL 63 Ampligen ® 63 Mipomersen 63 Adenuric R 63 anti EGFR antibody 63 gepirone ER 63 CytoFabTM 63 selective immunoproteasome inhibitor 63 ELIQUIS 63 Akt inhibitor 63 PANVAC VF 63 Tarceva TM 63 including eniluracil ADH 63 dasatinib Sprycel 63 molecular imaging radiopharmaceutical 63 DP VPA 63 severe hypercholesterolemia 63 DepoDur 63 successfully commercialize Iluvien 63 Increlex R 63 Virulizin R 63 Actimmune ® 63 anti CD3 monoclonal 63 humanized monoclonal 63 investigational monoclonal antibody 63 Monoclonal antibody 63 formerly LymphoStat B 63 cetuximab Erbitux R 63 Achieves Primary Endpoint 63 RH1 63 Clolar ® 63 miconazole MBT 63 Sphingomab TM 63 novel immunotherapeutic 63 Xerecept 63 PEGylated Fab fragment 63 Therapeutic Vaccine 63 Removab 63 Noxafil 63 rituximab Rituxan 63 sapropterin dihydrochloride 63 Bayer Onyx 63 Bicifadine 63 atacicept 63 Submits Response 63 Onco TCS 63 Alimta pemetrexed 63 Vidaza R 63 ALN PCS 63 Epimmune 63 aerosolized AAT 63 Cinryze ™ 63 JAK2 Inhibitor 63 elotuzumab 63 docetaxel Taxotere R 63 SAR# [004] 63 Arno Therapeutics 63 terlipressin 63 Alzhemed TM 63 Eculizumab 63 Kepivance 63 amrubicin 63 Auxilium Pharma 63 INCB# [001] 63 ATL# [002] 63 Zenapax 63 Preotact 63 Aptivus ® 63 registrational trial 63 octreotide implant 63 Oracea ® 63 oral beclomethasone dipropionate 63 Loramyc R 63 Adentri 63 PROVENGE ® 63 epigenetic therapies 63 Submits IND 63 ZALBIN 63 ® natalizumab 63 forodesine 63 KIACTA ™ 63 Investigational Treatment 63 Aurograb 63 bevacizumab Avastin ® 63 Dacogen injection 63 Febuxostat 63 Tocosol Paclitaxel 63 Amplimexon 63 autologous cellular immunotherapy 63 AVAX 63 Diamyd ® 63 Phase IIb III 63 Synvisc ONE 63 adalimumab Humira 63 tiapamil 63 HIV integrase inhibitor 63 humanised monoclonal antibody 63 chronic thromboembolic pulmonary 63 STELARA TM 63 Presents Preclinical Data 63 AB OMXS BINV 63 EGS# 63 seliciclib CYC# 62 LHRH receptor positive 62 Orathecin 62 cutaneous T 62 FDA Accepts 62 SOLVAY PHARMACEUTICALS 62 Vantas 62 Kamada AAT 62 Davanat 62 osteolytic bone disease 62 endothelin antagonist 62 liposomal formulation 62 PD LID 62 Receives Marketing Authorization 62 euro adhoc Intercell AG 62 IAP inhibitors 62 anticancer compound 62 PREOS R 62 Enkephalin 62 Pazopanib 62 reslizumab 62 Tesamorelin 62 Phase 2b Clinical Trial 62 Gemzar ® 62 panitumumab Vectibix 62 romidepsin 62 dasatinib Sprycel ® 62 RELOVAIR ™ 62 receptor tyrosine kinase inhibitor 62 romazarit 62 Qutenza TM 62 Impavido R 62 ASG 5ME 62 imatinib Gleevec ® 62 CAMPATH R 62 TOCOSOL Paclitaxel 62 ularitide 62 valopicitabine NM# 62 oral methylnaltrexone 62 Pirfenidone 62 Vitaxin 62 Receives Orphan Drug 62 daptomycin 62 EHT AGN 62 oral antiviral 62 candidates Azedra TM 62 ZADAXIN ® 62 selective modulator 62 Luteinizing Hormone Releasing Hormone 62 TAXOL 62 Mirapexin 62 Fibrillex TM 62 #D#C# 62 ATIR 62 sitaxsentan sodium 62 HCV polymerase 62 pain palliation 62 ELACYT 62 Oncoscience AG 62 personalized cellular immunotherapy 62 Zenpep 62 PDX pralatrexate 62 HGS# 62 corticosteroid dexamethasone 62 Iluvien ® 62 GTC recombinant form 62 Vidaza azacitidine 62 Benlysta belimumab 62 MEK inhibitor 62 Clofarabine 62 oral talactoferrin 62 OSI Tarceva 62 monoclonal antibody therapeutics 62 ELND-#/AZD-# 62 chronic eosinophilic leukemia 62 Maxy G# 62 post herpetic neuralgia PHN 62 Talabostat 62 Preotact R 62 Cutaneous T 62 Azacitidine 62 ocrelizumab 62 Novartis NVS Snapshot Report 62 HGS ETR2 62 INS# [001] 62 THR beta agonist 62 PhotoCure 62 immatics 62 pediatric Crohn disease 62 R#/MEM 62 Phase III Pivotal 62 novel immunotherapies 62 Oasmia 62 BRAF inhibitor 62 Dexilant 62 CEQ# 62 Raptiva R 62 Sanvar R 62 GSK '# 62 rxRNA 62 Intravenous Human 62 Rilonacept 62 Triapine 62 inhaled formulation 62 Elvitegravir 62 Onalta ™ 62 TRAIL receptor antibodies 62 Orphan Drug status 62 GTC recombinant human 62 rheumatoid arthritis psoriatic arthritis 62 ISTODAX 62 ZEFTERA TM Zevtera TM 62 enzastaurin 62 investigational HCV polymerase 62 PLAVIX ® 62 Empatic TM 62 ketolide antibiotic 62 Novel Oral 62 NTDDS 62 Amrubicin 62 Onalta 62 INSPIRE Trial Phase III 62 Prism Pharmaceuticals 62 Vernalis plc 62 Sebivo 62 torsemide ER 62 immune modulating 62 Tyzeka 62 ThermoDox R 62 BLP# Liposome Vaccine 62 cell lymphoma CTCL 62 metaglidasen 62 Evoltra TM 62 Cellegesic 62 Presents Preclinical 62 interferon gamma 1b 62 SPL# Gel vaginal microbicide 62 Anavex #-# 62 docetaxel Injection Concentrate 62 oral proteasome inhibitor 62 eprotirome 62 highly purified pasteurized 62 nalbuphine ER 62 pharmacokinetic PK study 62 Joulferon 62 Campto 62 TEMODAL 62 sunitinib malate 62 Regeneron Pharma 62 Cloretazine R 62 Trastuzumab 62 MAA submission 62 Phase IIIb clinical 62 oral picoplatin 62 Firazyr 62 Panzem ® 62 Phase 2a Trial 62 intranasal formulation 62 R bendamustine hydrochloride 62 sodium thiosulfate STS 62 Amgen Neulasta R 62 mesylate 62 Seattle Genetics SGEN 62 TKM ApoB 62 HCV protease inhibitors 62 PRN FDA Approves 62 Degarelix 62 FDA Approvable Letter 62 Drug Candidate 62 rALLy clinical trial 62 myelodysplastic myeloproliferative diseases 62 toenail onychomycosis 62 Plicera 62 EVIZON TM 62 Trofex TM 62 Thalomid ® 62 catheter occlusion 62 Tovaxin TM 62 hypoxia activated prodrug 62 IMiD 62 Remicade infliximab 62 orBec 62 talactoferrin 62 vemurafenib 62 Increlex ® 62 Pivotal Phase III 62 Liprotamase 62 squamous non 62 Hybridon 62 Bio3 Research 62 tafamidis 62 Affimed Therapeutics AG 62 BCG refractory carcinoma 62 Chimigen TM 62 GA GCB 62 DOS# 62 TRISENOX 62 JAK inhibitor 62 Hedgehog antagonist 62 Lixivaptan 62 Gleevec resistant 62 Reverset 62 Surfaxin LS 62 tubulin inhibitor 62 Pyridorin 62 Patient Enrollment 62 Revotar 62 Genentech Roche 62 Pruvel 62 Theratope 62 Actemra tocilizumab 62 DU #b 62 MAXY alpha 62 small molecule thrombopoietin 62 Investigational Oral 62 Temodar ® 62 Amigal 62 Cethrin R 62 Valdoxan 62 Tibotec Therapeutics division 62 Biologic License Application BLA 62 EndoTAG TM 62 Eligard ® 62 Teplizumab 62 TRO# 62 Rasagiline 62 Phase IIb Trial 62 MKC# MKC# PP 62 Aurora Kinase 62 Investigational Compound 62 alemtuzumab MS 62 Aliskiren 62 Progressive Multifocal Leukoencephalopathy 62 Dasatinib 62 novel oral anticoagulant 62 Hepatitis C Virus HCV 62 lucinactant 62 MERREM 62 BRIM2 62 KNS # 62 pegylated liposomal doxorubicin 62 MyVax ® 62 RAPTIVA R 62 outlicensed 62 aurora kinase 62 Telzir 62 commercialize deforolimus 62 desvenlafaxine 62 adenosine A2A 62 Successfully Completes Phase 62 Solzira 62 LHRH antagonist 62 multicenter Phase II 62 Abbokinase 62 oxymorphone ER 62 SCHWARZ PHARMA 62 XYOTAX TM 62 targeting CD# 62 Hepatocellular Carcinoma HCC 62 HSP# inhibitor 62 Lodotra TM 62 hepatitis C HCV 62 NXL# 62 OMNARIS Nasal Spray 62 ALVESCO R 61 Lupuzor 61 Bonefos 61 Virulizin 61 ZFP Therapeutics 61 LibiGel ® 61 Vilazodone 61 novel histone deacetylase 61 CIMZIA TM certolizumab pegol 61 MEK inhibitors 61 MNTX 61 Multiple Ascending Dose 61 novel emulsion formulation 61 drug conjugate 61 PSMA ADC 61 SomatoKine 61 Vascular Wrap TM 61 Proellex TM 61 Avastin bevacizumab 61 trastuzumab DM1 61 Belimumab 61 Allovectin 7 ® 61 beta secretase inhibitors 61 HyperAcute 61 Naglazyme R 61 Nipent R 61 PAION AG 61 Targretin capsules 61 Nitec 61 ocular formulation 61 epothilones 61 canakinumab 61 Iloperidone 61 Quark Pharmaceuticals 61 Elagolix 61 Sudhir Agrawal D.Phil 61 Ixabepilone 61 myelofibrosis polycythemia vera 61 IRX 2 61 Pancreate 61 Arranon 61 Eligard R 61 Pirespa 61 AERx iDMS 61 faropenem medoxomil 61 intravenous acetaminophen 61 humanized anti 61 Brilique 61 L BLP# 61 DPP4 inhibitor 61 REMOXY R 61 Protexia R 61 THALOMID 61 depsipeptide 61 VitiGam TM 61 lixivaptan 61 OncoGel 61 Urocidin TM 61 somatostatin analog 61 MAXY VII 61 alefacept 61 Telatinib 61 HCD# [002] 61 Octreotide 61 XL# XL# XL# XL# 61 erlotinib Tarceva ® 61 Tramiprosate ALZHEMED TM 61 SNT-MC#/idebenone 61 Firazyr ® 61 faropenem 61 EnzymeRx 61 ZK EPO 61 sargramostim 61 Aganocide 61 EP #R 61 mGluR2 NAM 61 Receives Milestone Payment 61 Nexavar tablets 61 lenalidomide dexamethasone 61 AAG geldanamycin analog 61 midstage trials 61 Copegus ribavirin 61 aripiprazole Abilify 61 Rapinyl 61 OXi# 61 POSIDUR TM ELADUR TM 61 acyclovir Lauriad ® 61 oral dual endothelin 61 SuperAntibody 61 ridaforolimus 61 Diamyd R 61 Tigecycline 61 HCl Tablets 61 ENZON 61 LUVENIQ 61 Syntonix 61 sitagliptin metformin 61 CMV vaccine 61 levocetirizine 61 Marketing Authorisation Application MAA 61 Hexvix ® 61 HyACT 61 Receives Approvable Letter 61 CD# monoclonal antibody 61 Apoptone 61 rThrombin 61 Dynepo TM 61 Gendux AB 61 brivaracetam 61 neratinib 61 selective estrogen receptor modulator 61 Announces Poster Presentations 61 Zolinza 61 Zarnestra 61 Initiates Dosing 61 Optiquel ™ 61 ORENCIA ® 61 Desmoteplase 61 RoACTEMRA 61 Myrexis Inc. 61 Phase III Clinical Trial 61 Amigal TM 61 Mycamine 61 chronic idiopathic thrombocytopenic purpura 61 RNA antagonists 61 eprodisate KIACTA TM 61 MT#/MEDI-# 61 Pradefovir 61 Orphan Designation 61 investigational antiplatelet agent 61 Drug Eluting Stent System 61 Orapred ODT 61 Ozarelix 61 Vidofludimus 61 Mycograb 61 Luveris 61 Tyrima 61 SANOFI AVENTIS 61 CCR9 antagonist 61 NovaBay Aganocide compounds 61 pertuzumab 61 RNAi therapeutic targeting 61 granted Ortec 61 HepaSphere 61 EGRIFTA 61 Aloxi R 61 oral ridaforolimus 61 nucleoside analog 61 lintuzumab SGN 61 Cutanea 61 candidate REP# 61 prokinetic agent 61 Elotuzumab 61 Panzem 61 oropharyngeal candidiasis OPC 61 sapacitabine CYC# 61 JAK1 61 baminercept 61 THALOMID R 61 Plenaxis TM 61 velafermin 61 immunotherapeutics 61 telomerase therapeutic 61 ALN TTR 61 A3 adenosine receptor 61 Edurant 61 oral Factor Xa 61 small molecule glucokinase 61 NitroMist TM 61 NASDAQ PHRM 61 ProtAffin 61 PRT# 61 Voraxaze 61 sorafenib Nexavar 61 Pivotal Study 61 Aceon 61 Argatroban 61 Zytiga 61 delivers fluocinolone acetonide FA 61 schizophrenia CIAS 61 Irinotecan 61 EOquin 61 MKC# 61 Roche Trimeris 61 ZOLINZA 61 corticotropin injection 61 Mycophenolate Mofetil 61 Akela Pharma Inc. 61 phase IIb III 61 Pralatrexate 61 gastrointestinal stromal tumors GIST 61 Egrifta 61 ProFibrix 61 gefitinib Iressa 61 Luveniq 61 aflibercept 61 KRN# 61 XERECEPT R 61 HuMax EGFr